Gert Fricker

13.2k total citations
258 papers, 10.6k citations indexed

About

Gert Fricker is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gert Fricker has authored 258 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Oncology, 83 papers in Molecular Biology and 56 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gert Fricker's work include Drug Transport and Resistance Mechanisms (120 papers), Pharmacological Effects and Toxicity Studies (52 papers) and Advanced Drug Delivery Systems (35 papers). Gert Fricker is often cited by papers focused on Drug Transport and Resistance Mechanisms (120 papers), Pharmacological Effects and Toxicity Studies (52 papers) and Advanced Drug Delivery Systems (35 papers). Gert Fricker collaborates with scholars based in Germany, United States and Switzerland. Gert Fricker's co-authors include David S. Miller, Jürgen Drewe, Björn Bauer, Martin Brandl, Heike Gutmann, Anne Mahringer, Jörg Huwyler, Anika M. S. Hartz, Christoph Beglinger and Kerstin J. Frank and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gert Fricker

252 papers receiving 10.3k citations

Peers

Countries citing papers authored by Gert Fricker

Since Specialization

Citations

This map shows the geographic impact of Gert Fricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Fricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Fricker more than expected).

Fields of papers citing papers by Gert Fricker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Fricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Fricker. The network helps show where Gert Fricker may publish in the future.

Co-authorship network of co-authors of Gert Fricker

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Fricker. A scholar is included among the top collaborators of Gert Fricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Fricker. Gert Fricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors 2025 ·Journal of Medicinal Chemistry ·(unknown), Francesca Massenzio, José Antonio Ortega, Debora Russo, Ilaria Penna, Federico Falchi, (unknown), Sabrina Petralla, Rita Scarpelli, (unknown), Gert Fricker, Michela Rosini, Andrea Cavalli, Barbara Monti, Anna Minarini, (unknown)	1
2	Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer’s disease 2024 ·Frontiers in Pharmacology ·Elena Puris, Liudmila Saveleva, Seppo Auriola, Mikko Gynther, Katja M. Kanninen, Gert Fricker	1
3	Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines 2024 ·Pharmacological Reports ·(unknown), Gert Fricker, (unknown), Branko Popović	0
4	Oral Delivery of mRNA by Liposomes Functionalized with Cell-Penetrating Peptides 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Walter Mier, Gert Fricker, Philipp Uhl	1
5	The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy 2023 ·Pharmaceutics ·Elena Puris, Gert Fricker, Mikko Gynther	37
6	Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α_vβ₃ Targeting 2023 ·ACS Omega ·(unknown), (unknown), Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler	10
7	A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy 2023 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), Maria Jäntti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Juha R. Savinainen, Elena Puris, Gert Fricker, Mikko Gynther, Ulrika Julku, Henri J. Huttunen, Stephen J. Haggarty, Timo T. Myöhänen	17
8	Synthesis and Characterization of Biodegradable Poly(butyl cyanoacrylate) for Drug Delivery Applications 2022 ·Polymers ·(unknown), (unknown), Samuel O. Kyeremateng, Gert Fricker	11
9	Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable? 2022 ·Pharmaceutics* ·(unknown), Xia Cheng, (unknown), Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler	10
10	Targeting Transporters for Drug Delivery to the Brain: Can We Do Better? 2022 ·Pharmaceutical Research ·Elena Puris, Gert Fricker, Mikko Gynther	54
11	Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease 2022 ·Pharmaceutics ·Mikko Gynther, (unknown), Sanna Loppi, Paula Korhonen, Katja M. Kanninen, Tarja Malm, Jari Koıstınaho, Seppo Auriola, Gert Fricker, Elena Puris	10
12	Potential and Limits of Kidney Cells for Evaluation of Renal Excretion 2021 ·Pharmaceuticals ·Christian Lechner, Ursula Mönning, Andreas Reichel, Gert Fricker	11
13	Trends in Liposomal Nanocarrier Strategies for The Oral Delivery of Biologics 2021 ·Nanomedicine ·(unknown), (unknown), (unknown), Gert Fricker, Walter Mier, Philipp Uhl	7
14	Crossing the blood-brain barrier: A review on drug delivery strategies using colloidal carrier systems 2021 ·Neurochemistry International ·Anne Mahringer, Elena Puris, Gert Fricker	23
15	Sugar Codes Conjugated Alginate: An Innovative Platform to Make a Strategic Breakthrough in Simultaneous Prophylaxis of GERD and Helicobacter pylori Infection 2020 ·SHILAP Revista de lepidopterología ·(unknown), Abbas Yadegar, Saeed Balalaie, (unknown), Mohammad Reza Zali, Hidekazu Suzuki, Gert Fricker, Ismaeil Haririan	0
16	Impact of Zn²⁺ on ABC Transporter Function in Intact Isolated Rat Brain Microvessels, Human Brain Capillary Endothelial Cells, and in Rat in Vivo 2018 ·Molecular Pharmaceutics ·(unknown), (unknown), Gert Fricker	11
17	Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo 2002 ·Journal of Clinical Investigation ·(unknown), Björn Bauer, David S. Miller, (unknown), (unknown), Thilo Spruß, Günther Bernhardt, (unknown), Lothar Färber, Harald Gschaidmeier, Armin Buschauer, Gert Fricker	25
18	Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo 2002 ·Journal of Clinical Investigation ·(unknown), Björn Bauer, David S. Miller, (unknown), (unknown), Thilo Spruß, Günther Bernhardt, (unknown), Lothar Färber, Harald Gschaidmeier, Armin Buschauer, Gert Fricker	283
19	Excretion of a fluorescent rapamycin-derivative in proximal kidney tubules is mediated by P-glycoprotein. 1998 ·PubMed ·Gert Fricker, Jürgen Drewe, (unknown)	2
20	Extrahepatic obstructive cholestasis reverses the bile salt secretory polarity of rat hepatocytes. 1989 ·Journal of Clinical Investigation ·Gert Fricker, Lukas Landmann, Peter J. Meier	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact